Insider track record Other Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Luke Miels. Director active across 1 company, notably GSK plc. Cumulatively, 58 disclosures have been published. Activity tracked since 12 October 2023. The latest transaction was filed on 10 July 2026 (Vesting). Regulator: RNS (LSE). The full history is free.
Companies and markets linked to Luke Miels Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations 58 total
● Chief Executive Officer · Executives · 9 Jul 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:9668630-0 ● Chief Executive Officer · Executives · 10 Jul 2026 · GSK plc 1,241 shares @ £19.595 0.0032% mcap 0.1% of flow ISIN ISIN GB00BN7SWP63RNS:9668630-15 ● Chief Executive Officer · Executives · 9 Jul 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:0920c70b-f075-4c99-aba0-46720a29730a-0 ● Chief Executive Officer · Executives · 9 Jul 2026 · GSK plc 3 shares @ £19.63 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:9666294-9 ● Chief Executive Officer · Executives · 9 Jul 2026 · GSK plc 3 shares @ £19.63 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:06e0a094-373b-4460-b97c-91525b0dd5d9-9 ● Chief Executive Officer · Executives · 14 Apr 2026 · GSK plc 1,178 shares @ £21.67 0.0000% mcap 0.1% of flow ISIN ISIN GB00BN7SWP63RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-0 ● Chief Executive Officer · Executives · 9 Apr 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:66208821-3d67-43ba-837e-411f45d449f1-4 ● Chief Executive Officer · Executives · 9 Apr 2026 · GSK plc 2 shares @ £21.34 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:5b5d692c-e307-4a46-a436-f5464b4ee34b-0 ● Chief Executive Officer · Executives · 13 Feb 2026 · GSK plc 245,716 shares 0
ISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-0 ● Chief Executive Officer · Executives · 13 Feb 2026 · GSK plc 15,579 shares @ £21.6002 1.5% of flow ISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-1 ● Chief Executive Officer · Executives · 12 Feb 2026 · GSK plc 27,962 shares @ £21.50 2.7% of flow ISIN ISIN GB00BN7SWP63RNS:6207777f-2477-470b-868f-21f92714189a-0 ● Chief Executive Officer · Executives · 12 Feb 2026 · GSK plc 463,662 shares @ £21.50 44.5% of flow ISIN ISIN GB00BN7SWP63RNS:586c5c74-54b9-425a-a37c-ba21836ecce7-0 ● Chief Executive Officer · Executives · 9 Feb 2026 · GSK plc 4,549 shares @ £22.114 0.5% of flow ISIN ISIN GB00BN7SWP63RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-1 ● Chief Executive Officer · Executives · 9 Feb 2026 · GSK plc 60,334 shares 0
ISIN ISIN GB00BN7SWP63RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-0 ● Chief Executive Officer · Executives · 10 Feb 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:8df504c6-f415-410b-a190-e5ddcfc0debe-0 ● Chief Executive Officer · Executives · 8 Jan 2026 · GSK plc 3 shares @ £18.9433 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-0 ● Chief Executive Officer · Executives · 9 Jan 2026 · GSK plc 1,462 shares @ £18.91 0.1% of flow ISIN ISIN GB00BN7SWP63RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-24 ● Chief Commercial Officer · Executives · 10 Oct 2025 · GSK plc 1,670 shares @ £16.40 0.2% of flow ISIN ISIN GB00BN7SWP63RNS:5862277-5 ● Chief Commercial Officer · Executives · 9 Oct 2025 · GSK plc 3 shares @ £16.3933 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:5859068-4 ● Chief Commercial Officer · Executives · 10 Jul 2025 · GSK plc 3 shares @ £14.4433 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:5737340-13 ● Chief Commercial Officer · Executives · 10 Jul 2025 · GSK plc 1,862 shares @ £14.545 0.2% of flow ISIN ISIN GB00BN7SWP63RNS:5737340-24 ● Chief Commercial Officer · Executives · 16 Apr 2025 · GSK plc 2,098 shares @ £12.75 0.2% of flow ISIN ISIN GB00BN7SWP63RNS:5622701-5 ● Chief Commercial Officer · Executives · 10 Apr 2025 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:5617047-13 ● Chief Commercial Officer · Executives · 10 Apr 2025 · GSK plc 3 shares @ £13.1267 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:5615070-13 ● Chief Commercial Officer · Executives · 17 Feb 2025 · GSK plc 298,713 shares @ £14.35 39.7% of flow ISIN ISIN GB00BN7SWP63RNS:5546836-5 25 of 58 declarations
Load more (33 remaining) About Luke Miels Luke Miels is Chief Executive Officer at GSK plc. He has 55 filings in total, and across the 55 sampled filings between 2023-10-13 and 2026-07-14, the aggregated amounts show EUR 708 of buys and EUR 1304780 of sells.